THC Global to enter Asia
THC Global Group (ASX: THC) has partnered with Malaysian...
Featured
QLD Repeals Public Health (Medicinal Cannabis) Act 2016
QLD to streamlined medicinal cannabis access.
Creso shows increasing growth of non-medical CBD products.
Creso Pharma (ASX: CPH) has released an update on...
Tilray expands clinical research support
Tilray (NASDAQ: TLRY) has announced the support of two...
MGC Pharma delivers update on R&D and commercial strategy
MGC Pharmaceuticals (ASX: MXC, OTC: MGCLF) has released an...
RotoGro Secures Substantial USA Contract
RotoGro's (ASX: RGI) USA subsidiary Global Fertigation Solutions has...
Health House International gains Satipharm distribution.
The medicinal cannabis product has been available since 2017.
BOD completes Phase I on medicinal cannabis wafer
The trial shows the product is safe for human use.
Impression Healthcare goes deep on clinical research.
The partnership is for medicinal cannabis research and commercialisation.
Australia medicinal cannabis report shows falling prices.
The report details key insights on patient numbers, consumption, and pricing.